PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"
Visit https://www.peervoice.com/BGE860 to view the entire programme with slides. After completing “"Jacob Pontoppidan Thyssen, MD, PhD, DmSci - A Clinical Round-Up on the Impact of COVID-19 in Patients With Atopic Dermatitis: Management; Outcomes; Vaccination"”, participants will be able to: Summarise the impact of COVID-19 preventive measures on patients’ atopic dermatitis (AD) activity; Explain the difference in COVID-related outcomes in patients on immunomodulatory therapies for AD compared with patients who are not receiving immunomodulatory therapy for AD; Propose practical COVID-19 vaccine strategies for patients with AD who are receiving a biologic agent